Alessandro Ciarcia: Connecting Expertise and Innovation to Transform the Future of TTP Management at ISTH 2026
Alessandro Ciarcia, Marketing Director at Sanofi, shared a post on LinkedIn:
“Excited to be at ISTH 2026, where the global thrombosis and hemostasis community comes together to share knowledge, challenge ideas, and drive progress for patients.
One of the greatest values of this meeting is the opportunity to engage in meaningful conversations with leading experts, clinicians, researchers, and industry partners who are advancing our understanding of thrombotic thrombocytopenic purpura (TTP)—a rare, life-threatening disease where continued collaboration, innovation, and scientific exchange can have a meaningful impact on patient outcomes.
Looking forward to learning from the latest science, exchanging perspectives, and building connections that help move the field forward.”
Stay Updated with the Latest ISTH 2026 Updates on Hemostasis Today.
-
Oct 20, 2026, 01:43Oliver Weingärtner: Deprescribing of Lipid Lowering Drug after MI is Associated with Cardiovascular Events
-
Oct 19, 2026, 19:44Where You Live Should not Determine Whether You Receive Care – World Federation of Hemophilia
-
Oct 19, 2026, 19:42Belen Bianco: Prevention, Early Suspicion and an Interdisciplinary Approach Save Lives
-
Oct 19, 2026, 19:40Christina Chrysohoou: Catheter-Based LAAC vs OAC for Stroke Prevention in Atrial Fibrillation
-
Oct 19, 2026, 19:38Matthew Flick: A Two-Day Research Meeting on Fibrinogen, Hemostasis and Thrombosis
-
Oct 19, 2026, 19:37Hayat Saeed: Excited to Share Our Publication on the FGL1–Hepcidin Axis in Iron Homeostasis and Disease
-
Oct 19, 2026, 19:08IPAW 2026 Comes to a Close, but the Work Continues – PPTA
-
Oct 19, 2026, 17:44Paul Riley: Moderating a Webinar on Anticoagulation Monitoring
-
Oct 19, 2026, 16:36Christopher Pittman: Blood Clot Prevention Cannot End at Hospital Discharge